Detalhe da pesquisa
1.
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.
J Immunol
; 191(5): 2514-2525, 2013 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23904160
2.
MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Eur J Immunol
; 43(9): 2398-408, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23716300
3.
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
J Control Release
; 172(1): 190-200, 2013 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-23933525
4.
Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate.
Vaccine
; 29(44): 7842-8, 2011 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-21816196